A detailed history of Spears Abacus Advisors LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 1,592 shares of ZTS stock, worth $281,720. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,592
Previous 1,592 -0.0%
Holding current value
$281,720
Previous $275,000 13.09%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$165.67 - $199.94 $33,134 - $39,988
200 Added 14.37%
1,592 $269,000
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $224,028 - $259,232
1,392 New
1,392 $239,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Spears Abacus Advisors LLC Portfolio

Follow Spears Abacus Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spears Abacus Advisors LLC with notifications on news.